Potent dihydroquinolinone dopamine D2 partial agonist/serotonin reuptake inhibitors for the treatment of schizophrenia

  • Yinfa Yan
  • , Ping Zhou
  • , David P. Rotella
  • , Rolf Feenstra
  • , Chris G. Kruse
  • , Jan Hendrik Reinders
  • , Martina van der Neut
  • , Margaret Lai
  • , Jean Zhang
  • , Dianne M. Kowal
  • , Tikva Carrick
  • , Karen L. Marquis
  • , Mark H. Pausch
  • , Albert J. Robichaud

Research output: Contribution to journalArticlepeer-review

Abstract

A dihydroquinolinone moiety was found to be a potent serotonin reuptake inhibitor pharmacophore when combined with certain amines. This fragment was coupled with selected D2 ligands to prepare a series of dual acting compounds with attractive in vitro profiles as dopamine D2 partial agonists and serotonin reuptake inhibitors. Structure-activity studies revealed that the linker plays a key role in contributing to D2 affinity, function, and SRI activity.

Original languageEnglish
Pages (from-to)2983-2986
Number of pages4
JournalBioorganic and Medicinal Chemistry Letters
Volume20
Issue number9
DOIs
StatePublished - 1 May 2010

Keywords

  • Dopamine D partial agonist
  • Schizophrenia
  • Serotonin reuptake inhibitor

Fingerprint

Dive into the research topics of 'Potent dihydroquinolinone dopamine D2 partial agonist/serotonin reuptake inhibitors for the treatment of schizophrenia'. Together they form a unique fingerprint.

Cite this